Ke Wei

4.3k total citations · 1 hit paper
60 papers, 3.2k citations indexed

About

Ke Wei is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ke Wei has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 25 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ke Wei's work include Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (12 papers) and Circular RNAs in diseases (12 papers). Ke Wei is often cited by papers focused on Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (12 papers) and Circular RNAs in diseases (12 papers). Ke Wei collaborates with scholars based in China, United States and Italy. Ke Wei's co-authors include Fengming Yang, Chuchu Shao, Mengyan Xie, Hua Shen, Yongqian Shu, Xinming Jing, Glenn D. Rosen, Chunfeng Pan, Wenteh Chang and Yang Xia and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and FEBS Letters.

In The Last Decade

Ke Wei

56 papers receiving 3.2k citations

Hit Papers

Role of hypoxia in cancer therapy by regulating the tumor... 2019 2026 2021 2023 2019 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Wei China 26 1.9k 1.4k 494 466 411 60 3.2k
Lin Zhao China 37 2.6k 1.4× 1.5k 1.1× 266 0.5× 187 0.4× 852 2.1× 97 4.4k
Yi Luo China 32 1.8k 1.0× 756 0.6× 660 1.3× 208 0.4× 854 2.1× 149 4.3k
Yuanyuan Yang China 29 1.8k 1.0× 535 0.4× 271 0.5× 344 0.7× 612 1.5× 145 3.0k
Weiguang Wang United Kingdom 30 1.4k 0.8× 631 0.5× 313 0.6× 258 0.6× 795 1.9× 81 2.9k
Qinjie Weng China 29 1.3k 0.7× 436 0.3× 294 0.6× 229 0.5× 293 0.7× 96 3.0k
Chunhong Yan United States 38 3.0k 1.6× 1.4k 1.0× 791 1.6× 241 0.5× 1.1k 2.7× 106 4.8k
Zhengdong Cai China 28 1.4k 0.8× 628 0.5× 588 1.2× 508 1.1× 733 1.8× 91 2.9k
Xiaobing Liu China 28 2.2k 1.2× 1.1k 0.8× 631 1.3× 172 0.4× 869 2.1× 150 4.6k
Xi Yang China 28 1.9k 1.0× 885 0.6× 1.3k 2.6× 392 0.8× 454 1.1× 144 3.6k
Yangyang Yu China 22 2.5k 1.3× 1.6k 1.1× 2.2k 4.4× 373 0.8× 479 1.2× 68 4.4k

Countries citing papers authored by Ke Wei

Since Specialization
Citations

This map shows the geographic impact of Ke Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Wei more than expected).

Fields of papers citing papers by Ke Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Wei. The network helps show where Ke Wei may publish in the future.

Co-authorship network of co-authors of Ke Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Wei. A scholar is included among the top collaborators of Ke Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Wei. Ke Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hongchang, Linghua Zhu, Chenghao Fu, et al.. (2025). Endoplasmic reticulum stress related super-enhancers suppress cuproptosis via glycolysis reprogramming in lung adenocarcinoma. Cell Death and Disease. 16(1). 316–316. 6 indexed citations
2.
Qi, Xiaokun, et al.. (2025). Roles of TREM2 in Alzheimer’s disease. Translational Neurodegeneration. 14(1). 55–55.
3.
Dai, Lijun, Jiannan Wang, Lanxia Meng, et al.. (2025). The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson’s disease. PLoS Biology. 23(2). e3002974–e3002974. 4 indexed citations
4.
Dai, Lijun, et al.. (2024). Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies. Cellular and Molecular Life Sciences. 81(1). 382–382. 12 indexed citations
6.
7.
Wei, Xinyu, Haitao Zhu, Shiwen Zhang, et al.. (2023). Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b. Gene. 860. 147230–147230. 27 indexed citations
8.
Bian, Jinhui, Yi Ding, Song Wang, et al.. (2023). Celastrol confers ferroptosis resistance via AKT/GSK3β signaling in high-fat diet-induced cardiac injury. Free Radical Biology and Medicine. 200. 36–46. 23 indexed citations
10.
Chen, Long, Ke Wei, Jun Li, et al.. (2022). Integrated Analysis of LncRNA-Mediated ceRNA Network in Calcific Aortic Valve Disease. Cells. 11(14). 2204–2204. 10 indexed citations
11.
Peng, Yu, et al.. (2021). CircTMCO3 Promotes Gastric Cancer Progression by Regulating miR-577/RAB14 Axis. Cancer Management and Research. Volume 13. 6079–6088. 8 indexed citations
12.
Wei, Ke, et al.. (2020). Molecular characterization of three caspases from Bostrychus sinensis and their transcriptional responses to bacteria and viruses. Journal of Fish Diseases. 43(4). 431–443. 6 indexed citations
13.
Xu, Jiaxin, Chen Yun-he, Rui Yang, et al.. (2020). Cucurbitacin B inhibits gastric cancer progression by suppressing STAT3 activity. Archives of Biochemistry and Biophysics. 684. 108314–108314. 44 indexed citations
14.
Zhong, Bing, Zhiqiang Qin, Hui Zhou, et al.. (2019). microRNA‐505 negatively regulates HMGB1 to suppress cell proliferation in renal cell carcinoma. Journal of Cellular Physiology. 234(9). 15025–15034. 5 indexed citations
15.
Xia, Yang, Ke Wei, Fengming Yang, et al.. (2019). miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC. Cell Death and Disease. 10(2). 112–112. 39 indexed citations
17.
Ma, Teng, Ye Zhao, Ke Wei, et al.. (2016). MicroRNA-124 Functions as a Tumor Suppressor by Regulating CDH2 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer. Cellular Physiology and Biochemistry. 38(4). 1563–1574. 43 indexed citations
18.
Liu, Lifen, Keiichi Kodama, Ke Wei, et al.. (2015). The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue. Diabetologia. 58(7). 1579–1586. 70 indexed citations
19.
Chang, Wenteh, Ke Wei, Lawrence Ho, et al.. (2014). A Critical Role for the mTORC2 Pathway in Lung Fibrosis. PLoS ONE. 9(8). e106155–e106155. 48 indexed citations
20.
Wei, Ke, et al.. (2007). Neural crest cell deficiency of c‐myc causes skull and hearing defects. genesis. 45(6). 382–390. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026